IDXX

爱德士实验室

• Dow Jones·1d ago

  Revvity Inc. Stock Advances 7.5%, Outperforms Peers

• PUBT·1d ago

  Insulet names ex-IDEXX CEO Jay Mazelsky to board, effective July 1, 2026

• Dow Jones·2d ago

  Revvity Inc. Stock Rallies 5.7%, Outperforms Peers

• Simply Wall St·2d ago

  Are IDEXX Laboratories’ (IDXX) New SDMA and Tapeworm Tests Deepening Its Diagnostics Moat?

• Dow Jones·06/17 20:35

  IDEXX Laboratories Inc. Stock Falls 4.7%, Underperforms Peers

• Simply Wall St·06/17 02:25

  IDEXX Laboratories (IDXX) Stock Could Be 23.6% Undervalued as Growth Narrative Faces P/E Test

• Benzinga·06/16 22:01

  Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years

• Simply Wall St·06/08 13:25

  Is IDEXX’s Broader Parasite Panel Quietly Reshaping the Diagnostics Narrative for IDXX?

• Simply Wall St·06/05 17:34

  A Look At Idexx Laboratories (IDXX) Valuation After Earnings Beat, Outlook Upgrade And Product Expansion

• Seeking Alpha·06/02 11:45

  Zoetis: Potential Deep Value Play With 60%+ Upside Potential Dividend Investors Should Watch

• Seeking Alpha·06/02 08:12

  Nasdaq, S&P, Dow futures tread cautiously after Wall Street scales record highs

• Seeking Alpha·06/01 08:06

  Baron Asset Fund Q1 2026 Contributors, Detractors And Recent Activity

• Simply Wall St·06/01 07:18

  How Investors May Respond To IDEXX (IDXX) Expanding SDMA and Fecal Dx Integration in Diagnostics

• Seeking Alpha·06/01 03:08

  Tracking Terry Smith's Fundsmith 13F Portfolio - Q1 2026 Update

• Dow Jones·05/28 20:35

  Revvity Inc. Stock Advances 4.6%, Outperforms Peers